Education
About Us
Working with TipRanks
Follow Us
Thorsten Graef Insider Profile
4 Followers
Thorsten Graef, VP, Clinical Science at Pharmacyclics, holds 806.00 shares in Pharmacyclics (Ticker: PCYC).
Thorsten Graef Pharmacyclics (PCYC)VP, Clinical Science
Pharmacyclics (PCYC)
VP, Clinical Science
Not Ranked
Thorsten Graef has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Thorsten Graef does not currently own shares as a corporate insider.
A breakdown of Thorsten Graef's holdings
Insider Roles
Thorsten Graef does not currently hold a role as a corporate insider.
Roles that Thorsten Graef holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Thorsten Graef
Thorsten Graef's Trading History
List of latest transactions for each holding click on a transaction to see Thorsten Graef's performance on stock
You May Also Like
Thorsten Graef insider profile FAQ
What is the percentage of profitable transactions made by Thorsten Graef?
The percentage of profitable transactions made by Thorsten Graef is ―.
What is the average return per transaction made by Thorsten Graef?
The average return per transaction made by Thorsten Graef is ―.
What stocks does Thorsten Graef hold?
Thorsten Graef holds: PCYC stocks.
What was Thorsten Graef’s latest transaction?
Thorsten Graef latest transaction was an Uninformative Buy of $7.47K.
What was Thorsten Graef's most profitable transaction?
Thorsten Graef’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Thorsten Graef's role in Pharmacyclics?
Thorsten Graef's role in Pharmacyclics is VP, Clinical Science.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.